Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Ocular Surface Innate and Adaptive Immune Response in Dry Eye Disease

NCT06898853 is registered in ClinicalTrials.gov with The University of New South Wales as lead sponsor.

NCT NCT06898853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06898853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Ocular Surface Innate and Adaptive Immune Response in Dry Eye Disease
Lead sponsor
The University of New South Wales
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2025
Completion date
December 30, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease (ded)